Autism

Adia Nutrition Inc. Announces IRB Approval from BeyondBound for Adia Med’s Autism Clinical Study

Winter Park, Florida--(Newsfile Corp. - December 15, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine through…

17 hours ago

Adia Nutrition Inc. Announces IRB Approval from BeyondBound for Adia Med’s Autism Clinical Study

Winter Park, Florida--(Newsfile Corp. - December 15, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine through…

17 hours ago

Shrub Oak International School Reinforces Unwavering Commitment to Student Safety and Security

MOHEGAN LAKE, N.Y., Dec. 5, 2025 /PRNewswire/ -- Shrub Oak International School today announced enhanced details of its comprehensive, multi-layered…

1 week ago

LuxAI, Luxembourg Institute of Health, and University of Birmingham launch the first large-scale study of at-home, robot-led early development support for autistic children with QTrobot

LUXEMBOURG and BIRMINGHAM, England, Dec. 4, 2025 /PRNewswire/ -- LuxAI, together with the Luxembourg Institute of Health (LIH) and the…

2 weeks ago

UofL’s 2026 Grawemeyer psychology award winner recognized for contributions to autism research

LOUISVILLE, Ky., Dec. 4, 2025 /PRNewswire/ -- Sir Simon Baron-Cohen has received the 2026 Grawemeyer Award in Psychology, a distinction…

2 weeks ago

Tobinworld Calls for Early Action: Organization Urges Parents to Recognize Early Signs of Autism and Developmental Delays

Following Recent Feature, Tobinworld Highlights Why Early Awareness Can Change a Child's Future LOS ANGELES, CA / ACCESS Newswire /…

2 weeks ago

NRx Pharmaceuticals Announces US Food and Drug Administration (FDA) Receipt of ANDA for KETAFREE™, a Preservative-Free IV Ketamine

FDA has determined that NRx’s Abbreviated New Drug Application (ANDA) is “substantially complete” and received for review. Assigned GDUFA goal…

2 weeks ago

NRx Pharmaceuticals (NASDAQ: NRXP) and HOPE Therapeutics to Host Corporate Update Call

WILMINGTON, Del., Dec. 02, 2025 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical…

2 weeks ago

NRx Pharmaceuticals (NASDAQ:NRXP) and HOPE Therapeutics to Present at NobleCon21 – Noble Capital Markets’ Twenty First Annual Emerging Growth Equity Conference

WILMINGTON, Del., Dec. 01, 2025 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP, the “Company”, “NRx”), a clinical-stage biopharmaceutical company…

2 weeks ago